The t(2;5) in human lymphomas

Leukemia and Lymphoma

Volumn 29, Issue 3-4, 1998, Pages 249-256

  Kadin, Marshall E ^a   Morris, Stephan W ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Anaplastic large cell lymphoma; Human lymphomas; t(2; 5)

Indexed keywords

CD30 ANTIGEN; CHIMERIC PROTEIN; HYBRID PROTEIN; PROTEIN TYROSINE KINASE;

ADVANCED CANCER; B CELL LYMPHOMA; CANCER SURVIVAL; CHROMOSOME TRANSLOCATION 2; CONTROLLED STUDY; DNA TRANSFECTION; FLUORESCENCE IN SITU HYBRIDIZATION; HODGKIN DISEASE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INTERPHASE; LARGE CELL LYMPHOMA; LYMPHOMA; LYMPHOMATOID PAPULOSIS; METAPHASE CHROMOSOME; MOLECULAR GENETICS; NONHODGKIN LYMPHOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SKIN LYMPHOMA; SURVIVAL TIME;

EID: 0031868103     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199809068562     Document Type: Review

References (52)

1. Stein, H., Mason, D. Y., Gerdes, J., O'Connor, N., Wainscoat, J., Pallesen, G., Gatter, K., Falini, B., Delsol, G., Schwarting, R. and Lennert, K. (1985). The expression of Hodgkin's disease associated antigen Ki-1 in rective and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood, 66, 848-858.
2. Schwab, U., Stein, H., Gerdes, J., Lemke, H., Kirchner, H. H., Schaadt, M. and Diehl, V. (1982). Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature, 299, 65-67.
3. Agnarsson, B. A. and Kadin, M. E. (1988). Ki-1-positive anaplastic large-cell lymphoma: A morphologic and immunologic study of 19 cases. Am J Surg Pathol, 12, 264-74.
4. Bitter, M. A., Franklin, W. A., Larson, R. A., McKeithan, T. W., Rubin, C. M., Le Beau, M. M., Stephens, J. K. and Vardiman, J. W. (1990). Morphology in Ki-1 (CD30)-positive non-Hodgkin's lymphoma is correlated with clinical features and the presence of a unique chromosomal abnormality, t(2;5) (p23;q35). Am J Surg Pathol, 14, 305-16.
5. Chott, A., Kaserer, K., Augustin, I., et al. (1990). Ki-1 positive large cell lymphoma: a clinicopathologic study of 41 cases. Am J Surg Pathol, 14, 439-48.
6. + with high content of reactive histiocyes) Histopathology, 16, 383-91.
7. + T-cell lymphoma. Am J Surg Pathol, 17, 859-68.
8. ++): results of a prospective clinicopathologic study of 69 cases. Br J Haematol, 86, 513.
9. Kadin, M. E. Anaplastic large cell lymphoma and its morphologic variants. Cancer Surv., 30, in Lymphoma, edit. AC Wotherspoon, Cold Spring Harbor Laboratory Press, 1997. pp. 77-86.
10. Morgan, R., Smith, S. D., Hecht, B. K., Christy, V., Mellentin, J. D., Warnke, R. and Cleary, M. L. (1989). Lack of involvement of the c-fms and N-myc genes by chromosomal translocation t(2;5) (p23;q35) common to malignancies with features of so-called malignant histiocytosis. Blood, 73, 2155-64.
11. Fischer, P., Nacheva, E., Mason, D. Y. et al. (1988). A Ki-1 (CD30)-positive human cell line (Karpas 299) established from a high-grade non-Hodgkin's lymphoma, showing a 2;5 translocation and rearrangement of the T-cell receptor β chain gene. Blood, 72, 234-40.
12. Rimokh, R., Magaud, J.-P., Berger, F., Samarut, H., Coiffier, B., Germain, D. and Mason, D. Y. (1989). A translocation involving a specific breadkpoint on chromosome 5 is characteristic of anaplastic large-cell lymphoma. ('Ki-1 lymphoma'). Br J Haematol, 71, 31-36.
13. Le Beau, M. M., Bitter, M. A., Larson, R. A., Doane, L. A., Ellis, E. D., Franklin, W. A., Rubin, C. M. and Kadin, M. E. (1989). The t(2;5) (p23;q35): A recurring chromosomal abnormality in Ki-1-positive anaplastic large-cell lymphoma. Leukemia, 3, 866-70.
14. Kaneko, Y., Frizzera, G., Edamura, S., Maseki, N., Sakurai, M., Komoda, Y., Sakurai, M., Tanaka, H., Sasaki, M., Suchi, T., Kikuta, A., Wakasa, H., Hojo, H. and Mizutani, S. (1989). A novel translocation, t(2;5) (p23;q35) in childhood phagocytic large T-cell lymphoma mimicking malignant histiocytosis. Blood, 73, 806-13.
15. Morris, S. W., Kirstein, M. N., Balentine, M. B., Dittmer, K. G., Shapiro, D. B., Saltman, D. L. and Look, A. T. (1994). Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science, 263, 1281-84.
16. Borer, R. A., Lehner, C. F., Eppenberger, H. M. and Nigg, E. A. (1989). Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell, 56, 379-90.
17. Chan, W. Y., Liu, Q. R., Borjigin, J., Busch, H., Rennen, O. M., Tease, L. A. and Chan, K. (1989). Characterization of the cDNA encoding human nucleoplasmin and studies of its role in normal and abnormal growth. Biochem., 28, 1033-39.
18. Dumbar, T. S., Genetry, G. A. and Olson, M. O. J. (1993). Interaction of nucleolar phosphoprotein B23 with nucleic acids. Biochem., 28, 9495-9501.
19. Iwahara, T., Fujimoto, J., Wen, D., Cupples, R., Bucay, N., Arakawa, T., Mori, S., Ratzkin, B. and Yamamoto, T. (1997). Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system. Oncogene, 14, 439-49.
20. Morris, S. W., Naeve, C., Mathew, P., Hames, P. L., Kirstein, M. N., Cui, X. and Witte, D. P. (1997). ALK, the chromo-some 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphomc encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase. Oncogene, 14, 2175-2188..
21. Pulford, K., Lamant, L., Morris, S. W., Butler, L. H., Wood, K. M., Stroud, D., Delsol, G. and Mason, D. Y. (1997). Detection of anaplastic large cell lymphoma kinase (NPM)-ALK proteins in normal and neoplastic cells with monoclonal antibody ALK1. Blood, 89, 1394-1404.
22. Fujimoto, J. M., Shiota, M., Iwahara, N., Seki, N., Satoh, H., Mon, S. and Yamamoto, T. (1996). Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5). Prac Natl Acad Sci USA, 93, 4181-4186.
23. Bischof, D., Pulford, K., Mason, D. Y. and Morris, S. W. (1997). Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis. Mol Cell Biol, 176, 2312-25.
24. Rodriguez, G. A. and Park, M. (1994). Oncogenic activation of tyrosine kinases. Curr Opin Genet Dev, 4, 15-24.
25. Ladanyi, M. and Cavalchire, C. (1996). A molecular variant of the NPM-ALK rearrangement of Ki-1 lymphoma involving a cryptic ALK spice site. Genes, Chromosomes and Cancer, 15, 173-77.
26. Waggott, W., Lo, Y. M. D., Bastard, C. et al. (1995). Detection of NPM-ALK DNA rearrangement in CD30 positive large cell lymphoma. Br J Haematol, 89, 905.
27. Ladanyi, M. and Cavalchire, C. (1996). Detection of the NPM-ALK genomic rearrangement of Ki-1 lymphoma and isolation of the involved MPM and ALK introns. Diagnostic Molecular Pathology, 5, 154-8.
28. Sarris, A. H., Luthra, R., Papdimitracopoulou, V., Wassdorp, M., Dimopoulos, M. A., Mc Bride, J. A., Cabanillas, F., Duvic, M., Deisseroth, A. S., Morris, S. W. and Pugh, W. C. (1996). Amplification of genomic DNA demonstrates the presence of the t(2;5) (p23;q35) in anaplastic large cell lymphoma, but not in other non-Hodgkin's lymphoma, Hodgkin's disease or lymphomatoid papulosis. Blood, 88, 1771-79.
29. + primary cutaneous lymphoproliferative disorders and Hodgkin's disease. Blood, 88, 1765.
30. Shiota, M., Fujimoto, J., Takenaga, M., Satoh, H., Ichinohasama, R., Abe, M., Nakano, M., Yamamoto, T. and Mori, S. (1994). Diagnosis of t(2;5) (p23;q35)-associated Ki-1 lymphoma with immunohistochemistry. Blood, 84, 3648-52.
31. + lymphoproliferative disorders: Comparison with anaplastic large-cell lymphoma of nodal origin. Blood, 87, 3437-41.
32. Arber, D. A., Sun, L.-H. and Weiss, L. M. (1996). Detection of the t(2;5) (p23;q35) chromosomal translocation in large B-cell lymphomas other than anaplastic large cell lymphoma. Human Pathol, 27, 590-94.
33. Kaudewitz, P., Stein, H. and Dallenbach, F. (1989). Primary and secondary cutaneous Ki-2+ (CD30%) anaplastic large-cell lymphomas. Morphologic, immunohistologic, and clinical characteristics. Cancer, 135, 359-67.
34. Davis, T. H., Morton, C. C., Miller-Cassman, R., Balk, S. P. and Kadin, M. E. (1992). Hodgkin's disease, lymphomatoid papulosis and cutaneous T-cell lymphoma derived from a common T-cell clone. N Engl J Med, 326, 1115.
35. Hugh, K. and Poppema, S. (1990). Ki-1 (CD30) antigen expression on transformed follicular lymphomas. Lab Invest, 62, 46A.
36. NPM/ALK: A distinct clinicopathologic entity. Blood, 86, 1954.
37. Downing, J., Shurtleff, S. A., Zielnska, M., Curcio-Brint, A., Behm, F. G., Head, D. R., Sandlund, J. T., Weisenburger, D. D., Kossakowska, A. E., Thorner, P., Lorenzana, A., Ladanyi, M. and Morris, S. W. (1995). Molecular detection of the t(2;5) translocation of non-Hodgkin's lymphoma by reverse transcription-polymerase chain reaction. Blood, 85, 3416.
38. Elmberger, P. G., Lozano, M. D., Weisenburger, D. D., Sanger, W. and Chan, W. C. (1995). Transcripts of die NPM-ALK fusion gene in anaplastic large cell lymphoma, Hodgkin's disease, and reactive lymphoid lesions. Blood, 86, 3517-21.
39. Mathew, P., Sanger, W. G., Weisenburger, D. D., Valentine, M., Valentine, V., Pickering, D., Higgins, C., Hess, M., Cui, X., Srivastava, D. K. and Morris, S. W. (1997). Detection of the t(2;5) (p23;q35) and NPM-ALK fusion in non-Hodgkin's lymphoma by two-color fluorescence in situ hybridization. Blood, 89, 1678-85.
40. Leoncini, L., Del Vecchio, M. R., Kraft, R., Megha, T., Barbini, P., Cevenini, G., Poggi, S., Pileri, S., Tosi, P. and Cottier, H. (1990). Hodgkin's disease and CD30-positive anaplastic large cell lymphomas: a continuous spectrum of malignant disorders. A quantitative morphometric and immunohistologic study. Am J Pathol, 137, 1047.
41. Ladanyi, M., Cavalchire, G., Morris, S. W., Downing, J. and Filippa, D. A. (1994). Reverse transcriptase polymerase chain reaction for the Ki-1 anaplastic large cell lymphoma-associated t(2;5) translocation in Hodgkin's disease (published erratum appears in Am J Pathol, 146, 146, 1995). Am J Pathol, 145, 1296.
42. Herbst, H., Anagnostopoulos, I., Heinze, B., Durkop, H., Hummel, M. and Stein, H. ALK gene products in anaplastic large cell lymphomas and Hodgkin's disease. Blood. 86, 1694-1700.
43. Lamant, L., Meggetto, F., Al Saati, T., Brugieres, L., de Paillerets, B., Dastugue, N., Bemheim, A., Rubie, H., Terrier-Lacombe, M. J., Robert, A., Brousset, P., Rigal, F., Schlaifer, D., Shiota, M., Mori, S. and Delsol, G. (1996). High incidence of the t(2;5) (p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and p80 immunostaining. Blood, 87, 284.
44. Dirks, W. C., Zaborski, M., Jager, K., Challier, C., Shiota, M., Quenmeier, H. and Drexler, H. G. (1996). The (2:5) (p23:q35) translocation in cell lines derived from malignant lymphomas: absence of t(2;5) in Hodgkin-analogous cell lines. Leukemia, 10, 142-9.
45. Bullrich, F., Morris, S. W., Hummel, M., Pileri, S., Stein, H. and Croce, C. M. (1994). Nucleophosmin (NPM) gene rearrangements in Ki-1 -positive lymphomas. Cancer Res, 54, 2873.
46. Nhan, B. (1995). The presence of transcripts of the fusion of kinase gene ALK to nucleophosmin gene NPM in the t(2;5) (p23;q35) translocation defines subsets of non-Hodgkin's lymphoma with or without CD30 (Ki-1) expression and Hodgkin's disease. Mod Pathol. 8, 118A, (abstract).
47. Yee, H. T., Ponzoni, M., Merson, A., Goldstein, M., Scarpa, A., Chilosi, M., Menestrina, F., Pittaluga, S., De Wolf-Peeters, C., Shiota, M., Mori, S., Frizzera, G. and Inghirami, G. (1996). Molecular characterization of the t(2:5) (p23;q35) translocation in anaplastic large cell lymphoma (Ki-1) and Hodgkin's disease. Blood, 87, 1081-88.
48. Orscheschek, K., Merz, H., Hell, J., Binder, T., Bartels, H. and Feller, A. C. (1995). Large-cell anaplastic lymphoma-specific translocation (t[2;5] [p23;q35]) in Hodgkin's disease: Indication of a common pathogenesis? Lancet, 345, 87.
49. Poppema, S., Kaleta, J. and Hepperle, B. (1992). Chromosomal abnormilities in patients with Hodgkin's disease: Evidence for frequent involvement of the 14q chromosomal region but infrequent bcl-2 gene rearrangement in Reed-Sternberg cells. J Natl Cancer Inst, 84, 1789-93.
50. Trumper, L., Daus, H., Bonin, F. V., Loftin, U., Kupper, M. and Pfreundschuh, M. NPM/ALK fusion mRNA expression occurs in peripheral blood B-lymphocytes of healthy donors as evidenced by reverse transcriptase polymerase chain reaction (RT-PCR). Blood, 88 (Suppl 1), 225a (abstract).
51. Beylot-Barry, M., Lamant, L., Vergier, B., de Muret, A., Fraitag, S., Delord, B., Dubus, P., Baillant, L., Delaunay, M., Mac Grogan, G., Beylot, C., De Mascarel, A., Delsol, G. and Merlio, J.-P. (1996). Detection of t(2;5) (p23;q35) translocation by reverse transcriptase polymerase chain reaction and in situ hybridization in CD30-positive primary cutaneous lymphoma and lymphomatoid papulosis. Am J Pathol, 149, 483-92.
52. + lymphoproliferative disorders. J Cutaneous Pathology, in press.